Sleep changes during prophylactic treatment of migraine

dc.authoridSeydaoglu, Gulsah/0000-0002-0899-894X
dc.authoridDUMAN, Taskin/0000-0002-6552-4193
dc.contributor.authorDuman, Taskin
dc.contributor.authorDede, Ozlem H.
dc.contributor.authorUluduz, Derya
dc.contributor.authorSeydaoglu, Gulsah
dc.contributor.authorOkuyucu, Esra
dc.contributor.authorMelek, Ismet
dc.date.accessioned2024-09-18T20:32:51Z
dc.date.available2024-09-18T20:32:51Z
dc.date.issued2015
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractAims: To assess sleep quality in patients with primary headaches before and after prophylactic treatment using a validated sleep-screening instrument. Materials and Methods: A total of 147 patients, including 63 tension type headache (TTH) and 84 migraine patients were included. Patients were examined in terms of frequency and severity of headaches and sleep quality before and 12 weeks after prophylactic treatment with either propranolol or amitriptyline. Results: Baseline Visual Analogue Score (VAS) in migraine patients was 7.99 +/- 1.39 compared with 6.86 +/- 1.50 in TTH group (P < 0.001). VAS score after the first month of treatment was 6.08 +/- 1.88 in migraine patients and 5.40 +/- 1.61 in TTH (P = 0.023). VAS scores decreased after the third month of treatment to 4.32 +/- 2.29 in migraine patients and 4.11 +/- 1.66 in TTH patients (P = 0.344). The decrease was significant for patients treated with amitriptyline but not for those with propranolol. Baseline Pittsburgh Sleep Quality (PSQI) scores were 5.93 +/- 2.43 in migraine patients and 6.71 +/- 2.39 in TTH patients. Poor quality of sleep (PSQI = 6) prior to prophylactic treatment was observed in 61.4% of migraine patients and in 77.7% of TTH patients. Comparison of PSQI scores before and 3 months following treatment showed significantly improved quality of sleep in all treatment groups; the greatest significance was detected in migraine patients with initial PSQI scores of = 6 and treated with amitriptyline (P < 0.001). Conclusions: Increased understanding of routine objective sleep measures in migraine patients is needed to clarify the nature of sleep disturbances associated with primary headaches. This may in turn lead to improvements in headache treatments.en_US
dc.identifier.doi10.4103/0972-2327.160084
dc.identifier.endpage302en_US
dc.identifier.issn0972-2327
dc.identifier.issn1998-3549
dc.identifier.issue3en_US
dc.identifier.pmid26425007en_US
dc.identifier.scopus2-s2.0-84938877478en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage298en_US
dc.identifier.urihttps://doi.org/10.4103/0972-2327.160084
dc.identifier.urihttps://hdl.handle.net/20.500.12483/11176
dc.identifier.volume18en_US
dc.identifier.wosWOS:000359374700007en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWolters Kluwer Medknow Publicationsen_US
dc.relation.ispartofAnnals of Indian Academy of Neurologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectMigraineen_US
dc.subjectprophylactic treatmenten_US
dc.subjectsleep qualityen_US
dc.titleSleep changes during prophylactic treatment of migraineen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Tam Metin / Full Text
Boyut:
507.44 KB
Biçim:
Adobe Portable Document Format